UKX

(2S)-2-(2-oxidanylidenepyrrolidin-1-yl)butanamide

Created:2023-06-09
Last modified:  2024-05-01
Find related ligands:
Help
Chemical Details
Formal Charge0
Atom Count26
Chiral Atom Count1
Bond Count26
Aromatic Bond Count0
2D diagram of UKX
Toggle HydrogenToggle Labels
Chemical Component Summary
Name(2S)-2-(2-oxidanylidenepyrrolidin-1-yl)butanamide
Synonymslevetiracetam
Systematic Name (OpenEye OEToolkits)(2~{S})-2-(2-oxidanylidenepyrrolidin-1-yl)butanamide
FormulaC8 H14 N2 O2
Molecular Weight170.209
TypeNON-POLYMER
Chemical Descriptors
TypeProgramVersionDescriptor
SMILESCACTVS3.385CC[CH](N1CCCC1=O)C(N)=O
SMILESOpenEye OEToolkits2.0.7CCC(C(=O)N)N1CCCC1=O
Canonical SMILESCACTVS3.385 CC[C@H](N1CCCC1=O)C(N)=O
Canonical SMILESOpenEye OEToolkits2.0.7 CC[C@@H](C(=O)N)N1CCCC1=O
InChIInChI1.06 InChI=1S/C8H14N2O2/c1-2-6(8(9)12)10-5-3-4-7(10)11/h6H,2-5H2,1H3,(H2,9,12)/t6-/m0/s1
InChIKeyInChI1.06 HPHUVLMMVZITSG-LURJTMIESA-N
Drug Info: DrugBank

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License

DrugBank IDDB01202 
NameLevetiracetam
Groups
  • investigational
  • approved
DescriptionLevetiracetam is a drug within the pyrrolidine class that is used to treat various types of seizures stemming from epileptic disorders. It was first approved for use in the United States in 1999 and is structurally and mechanistically unrelated to other anti-epileptic drugs (AEDs).[L8606,L8600,L8615] Levetiracetam possesses a wide therapeutic index[L8615,A185918] and little-to-no potential to produce, or be subject to, pharmacokinetic interactions[L8606,L8600,L8615] - these characteristics make it a desirable choice over other AEDs, a class of drugs notorious for having generally narrow therapeutic indexes and a propensity for involvement in drug interactions.[A185927]
Synonyms
  • Levetiracetame
  • Levetiracetamum
  • Lévétiracetam
  • Levetiracetam
Brand Names
  • Pro-levetiracetam - 250
  • Levetiracetam Accord
  • Levetiractam
  • Apo-levetiracetam
  • Levetiracetam Actavis Group
IndicationLevetiracetam is indicated as an adjunctive therapy in the treatment of partial onset seizures in epileptic patients who are one month of age and older. Additionally, it is indicated as an adjunct in the treatment of myoclonic seizures in patients with juvenile myoclonic epilepsy who are 12 years of age and older, and in primary generalized tonic-clonic seizures in patients with idiopathic generalized epilepsy who are 6 years of age and older.[L8606] Levetiracetam is also available as an orally dissolvable tablet that is indicated as an adjunct in the treatment of partial onset seizures in patients with epilepsy who are 4 years of age and older and weigh more than 20kg.[L8609]
Categories
  • Acetamides
  • Amides
  • Anticonvulsants
  • Central Nervous System Agents
  • Central Nervous System Depressants
ATC-CodeN03AX14
CAS number102767-28-2

Drug Targets

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License
NameTarget SequencePharmacological ActionActions
Voltage-dependent N-type calcium channel subunit alpha-1BMVRFGDELGGRYGGPGGGERARGGGAGGAGGPGPGGLQPGQRVLYKQSIA...unknowninhibitor
Synaptic vesicle glycoprotein 2AMEEGFRDRAAFIRGAKDIAKEVKKHAAKKVVKGLDRVQDEYSRRSYSRFE...unknownagonist
5-hydroxytryptamine receptor 3AMLLWVQQALLALLLPTLLAQGEARRSRNTTRPALLRLSDYLLTNYRKGVR...unknownantagonist
ATP-dependent translocase ABCB1MDLEGDRNGGAKKKNFFKLNNKSEKDKKEKKPTVSVFSMFRYSNWLDKLY...unknownsubstrate
Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682

Related Resource References

Resource NameReference
Pharos CHEMBL1286
PubChem 5284583
ChEMBL CHEMBL1286
ChEBI CHEBI:6437
CCDC/CSD XOGMOX, YASGAC01, OMIVUB09, OFIQUR04, OFIQUR03, OFIQUR08, OFIQUR09, YASGAC, OFIQUR05, OFIQUR06, OMIVUB03, OMIVUB05, OMIVUB04, OMIVUB08, OFIQUR10, XOGMUD, OFIQUR12, ROQLEQ, XOGNIS, XOGPAM, OFIQUR, OFIQUR02, XOGMIR, ISUNAN, OFIQUR13, OMIVUB, XOGPEQ, OFIQUR07, OMIVUB02, OFIQUR14, OFIREC, OMIVUB06, YAMQAH, OFIQUR01, XOGNOY, XOGNEO, XOGNUE, OFIQUR11, OMIVUB01, OMIVUB07, ISUMUG, ISUMOA, ROQMAN
COD 4502986, 4511597, 4510876, 4510879, 2105492, 4510871, 4502988, 2202514, 2105494, 2105493, 7246751